Search Results | Diabetes Care | American Diabetes Association

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial

Merel E. Hellemons, MD, Frederik Persson, MD, Stephan J.L. Bakker, MD, Peter Rossing, MD, Hans-Henrik Parving, MD, Dick De Zeeuw, MD, Hiddo J. Lambers Heerspink, PHARMD

Diabetes Care 2011;34(9):2078–2083

DOI: https://doi.org/10.2337/dc11-0324

Published: 19 August 2011

View article

Journal Articles

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study

Johanna W. Nin, MD, Anders Jorsal, MD, Isabel Ferreira, PHD, Casper G. Schalkwijk, PHD, Martin H. Prins, MD, Hans-Henrik Parving, MD, Lise Tarnow, MD, Peter Rossing, MD, Coen D. Stehouwer, MD

Diabetes Care 2011;34(2):442–447

DOI: https://doi.org/10.2337/dc10-1087

Published: 20 January 2011

View article

Includes: Supplementary data

Journal Articles

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

Stine Elkjaer Nielsen, MD, Takeshi Sugaya, MD, PHD, Peter Hovind, MD, DMSC, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC

Diabetes Care 2010;33(6):1320–1324

DOI: https://doi.org/10.2337/dc09-2242

Published: 25 February 2010

View article

Journal Articles

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

Stine E. Nielsen, MD, Takeshi Sugaya, MD, PHD, Lise Tarnow, MD, DMSC, Maria Lajer, CANDSCI, Katrine J. Schjoedt, MD, Anne Sofie Astrup, MD, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC

Diabetes Care 2009;32(9):1684–1688

DOI: https://doi.org/10.2337/dc09-0429

Published: 05 June 2009

View article

Journal Articles

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Camilla Noelle Rathcke, MD, Frederik Persson, MD, Lise Tarnow, MD, DMSC, Peter Rossing, MD, DMSC, Henrik Vestergaard, MD, DMSC

Diabetes Care 2009;32(2):323–328

DOI: https://doi.org/10.2337/dc08-1144

Published: 01 February 2009

View article

Journal Articles

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

Anne Sofie Astrup, MD, Lise Tarnow, MD, Lotte Pietraszek, Casper G. Schalkwijk, MD, Coen D.A. Stehouwer, MD, Hans-Henrik Parving, MD, Peter Rossing, MD

Diabetes Care 2008;31(6):1170–1176

DOI: https://doi.org/10.2337/dc07-1960

Published: 01 June 2008

View article

Journal Articles

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Anders Jorsal, Noelynn Oliver, PHD, Peggy Roestenberg, PHD, Yasuhiko Ito, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC, Frans A. van Nieuwenhoven, PHD, Roel Goldschmeding, MD, PHD

Diabetes Care 2008;31(6):1177–1182

DOI: https://doi.org/10.2337/dc07-2469

Published: 01 June 2008

View article

Journal Articles

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes: Response to Farvid et al.

Peter Rossing, MD, DMSC, Mark E. Cooper, MD, PHD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2006;29(3):747–748

DOI: https://doi.org/10.2337/diacare.29.03.06.dc05-2144

Published: 01 March 2006

View article

Journal Articles

Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy

Sofia B. Ahmed, MD, MMSC, Peter Hovind, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, Deborah A. Price, MD, Lori M. Laffel, MD, MPH, M. Cecilia Lansang, MD, MPH, Radomir Stevanovic, MD, Naomi D.L. Fisher, MD, Norman K. Hollenberg, MD, PHD

Diabetes Care 2005;28(8):1988–1994

DOI: https://doi.org/10.2337/diacare.28.8.1988

Published: 01 August 2005

View article

Journal Articles

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?

Steen Andersen, MD, Lise Tarnow, MD, DMSC, Francois Cambien, MD, Peter Rossing, MD, DMSC, Tina R. Juhl, Jaap Deinum, MD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2003;26(5):1501–1506

DOI: https://doi.org/10.2337/diacare.26.5.1501

Published: 01 May 2003

View article

Journal Articles

Remission of Nephrotic-Range Albuminuria in Type 1 Diabetic Patients

Peter Hovind, MD, Peter Rossing, MD, DMSC, Lise Tarnow, MD, Henrik Toft, Jeppe Parving, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2001;24(11):1972–1977

DOI: https://doi.org/10.2337/diacare.24.11.1972

Published: 01 November 2001

View article

Journal Articles

Diabetes and Risk of Adverse Events With Calcium Antagonists

Hans-Henrik Parving, DMSC, Peter Rossing, MD

Diabetes Care 1998;21(10):1779–1780

DOI: https://doi.org/10.2337/diacare.21.10.1779

Published: 01 October 1998

View article

Journal Articles

Increased Plasma Apolipoprotein(a) Levels in IDDM Patients With Diabetic Nephropathy

Lise Tarnow, MD, Peter Rossing, MD, Flemming S Nielsen, MD, Birgitte V Hansen, BS, Jørn Dyerberg, MD, Hans-Henrik Parving, MD

Diabetes Care 1996;19(12):1382–1387

DOI: https://doi.org/10.2337/diacare.19.12.1382

Published: 01 December 1996

View article

Journal Articles

Fish Oil in Diabetic Nephropathy

Peter Rossing, MD, Birgitte V Hansen, Flemming S Nielsen, MD, Bjarne Myrup, MD, Gunhild Hølmer, MSC, Hans-Henrik Parving, DMSC

Diabetes Care 1996;19(11):1214–1219

DOI: https://doi.org/10.2337/diacare.19.11.1214

Published: 01 November 1996

View article

Journal Articles

Increased Tissue Factor Pathway Inhibitor Activity in IDDM Patients With Nephropathy

Hiroki Yokoyama, MD, Bjarne Myrup, MD, Peter Rossing, MD, Per B østergaard, PHD

Diabetes Care 1996;19(5):441–445

DOI: https://doi.org/10.2337/diacare.19.5.441

Published: 01 May 1996

View article

Journal Articles

Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V

Lise Tarnow, MD, Peter Rossing, MD, Mari-Anne Gall, MD, Flemming S Nielsen, MD, Hans-Henrik Parving, MD

Diabetes Care 1994;17(11):1247–1251

DOI: https://doi.org/10.2337/diacare.17.11.1247

Published: 01 November 1994

View article

NARROW

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes: Response to Farvid et al.

Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?

Remission of Nephrotic-Range Albuminuria in Type 1 Diabetic Patients

Diabetes and Risk of Adverse Events With Calcium Antagonists

Increased Plasma Apolipoprotein(a) Levels in IDDM Patients With Diabetic Nephropathy

Fish Oil in Diabetic Nephropathy

Increased Tissue Factor Pathway Inhibitor Activity in IDDM Patients With Nephropathy

Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only